Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
Search
Advanced Search
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Gongqiang Wu"

Article category

Keywords

More +

Publication year

"Gongqiang Wu"

Letters to the Editor
Discordant FIB-4 and liver stiffness in metabolic dysfunction-associated steatotic liver disease: Toward clinically coherent risk stratification: Letter to the Editor on “Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement”
Zhanna Zhang, Zichen Yu, Gongqiang Wu
Clin Mol Hepatol 2026;32(3):e297-e299.
Published online February 11, 2026
DOI: https://doi.org/10.3350/cmh.2026.0049
  • 1,166 View
  • 41 Download

Hepatic neoplasm

Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models
Zhanna Zhang, Gongqiang Wu
Clin Mol Hepatol 2025;31(1):e8-e9.
Published online November 6, 2024
DOI: https://doi.org/10.3350/cmh.2024.0958

Citations

Citations to this article as recorded by  Crossref logo
  • Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
    Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
    Clinical and Molecular Hepatology.2025; 31(1): e96.     CrossRef
  • 5,933 View
  • 54 Download
  • 1 Web of Science
  • Crossref
First First Prev Prev
Page of 1
Next Next Last Last
Clin Mol Hepatol : Clinical and Molecular Hepatology
Twitter